fda bans compounded semaglutide and tirzepatide says 'no clinical need' for weight loss drugs Zepbound copycats remain online despite

Ro is a great fit for adults who want a convenient and comprehensive approach to weight loss

So, here in the rest of this post I hope to answer them and share a more personal take

Promotes weight loss

This depends on your priorities and circumstances

#GLP1 #Healthcare #RestaurantIndustry #ConsumerBehavior #FoodTech #BusinessStrategy To view or add a comment, sign in GLP-1s are reshaping the food and beverage industry in real time

Conclusion Enavogliflozin added to metformin significantly improved glycemic control in patients with T2DM and was non-inferior to dapagliflozin 10 mg, suggesting enavogliflozin as a viable treatment option for patients with inadequate glycemic control on metformin alone